Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-05-31
1998-10-20
Scheiner, Toni R.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 71, 436 64, 436813, G01N 33574, G01N 3353
Patent
active
058244905
ABSTRACT:
Nuclear matrix proteins (NMP) which are characterized by a defined expression in tissue are provided. Also provided is an in vitro method for detecting prostate cancer in a sample employing a reagent that reacts with the NMP designated PC-1 (prostate cancer-1).
REFERENCES:
patent: 4882268 (1989-11-01), Penman et al.
Cupo, J F (1991) J. Chromatog. 569:389-406.
Getzenberg & Coffey (1990). Molec. Endocr. 4:1336-42.
Getzenberg et al. (1991) Biochem Biophys Res Comm 179:340-44.
Getzenberg et al. (1991) Cancer Res. 51:6514-20.
Partin & Coffey (1994) Rec Prog Horm Res 49:293-331.
Coffey Donald S.
Getzenberg Robert H.
Partin Alan W.
Scheiner Toni R.
The Johns Hopkins University School of Medicine
LandOfFree
Method for detecting prostate cancer using a reagent which binds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting prostate cancer using a reagent which binds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting prostate cancer using a reagent which binds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-242977